EQS-News: US Nuclear Corp Replaces Audit Firm With Simon & Edward LLP Effective Immediately, While Reducing 3rd Quarter Debt by Close to $800K
Werte in diesem Artikel
|
EQS-News: US Nuclear Corp
/ Key word(s): Financial
Werbung
LOS ANGELES, CA - November 4, 2025 (NEWMEDIAWIRE) - US Nuclear Corp (OTC: UCLE), is pleased to announce that the Company has Replaced the Audit Firm of Fruci & Associates II, PLLC, with Simon & Edwards LLP, Effective October 29, 2025. “We are actively looking to add an experienced VP of Sales, along with Sales Reps and Distributors to help service our growing customer list,” said Nikki Truax, Director of Operations of Overhoff Technology, our main Manufacturing and Sales Operation. “We are still working to cut our overall expenses by an additional 20-30% by the end of December, while continuing to reduce debt and strengthen the Balance Sheet,” said Mrs. Truax. “As we previously stated, we anticipate our 3rd quarter results to be profitable, and we’re looking for a profitable year ahead!” For sales and product information for US Nuclear, call Bob Goldstein at (818) 472-7071; for Overhoff call Ian Embry at (513) 248-2400, or Nikki Truax at (503) 646-5446. For investor information, call Jack Lennon at Chamberlain Capital (508) 360-8407 or jjlennon@comcast.net. Werbung News Source: US Nuclear Corp
04.11.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | US Nuclear Corp |
| United States | |
| ISIN: | US91733U1060 |
| EQS News ID: | 2223682 |
| End of News | EQS News Service |
|
|
2223682 04.11.2025 CET/CEST
Ausgewählte Hebelprodukte auf US Nuclear
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf US Nuclear
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle US Nuclear Aktie News
US Nuclear Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für US Nuclear nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
Keine Analysen gefunden.